Heron Therapeutics 2024年第四季度GAAP每股收益$0.02超出$(0.03)预期,销售额$40.78M超过$37.37M预期

财报速递02-27
Heron Therapeutics(纳斯达克代码:HRTX)报告季度每股收益为$0.02,超出分析师一致预期的$(0.03),上涨166.67%。相比去年同期的每股亏损$(0.07),这一收益增长了128.57%。公司报告的季度销售额为$40.78M,超出分析师预期的$37.37M,增长了9.14%。相比去年同期的$34.23M,销售额增长了19.13%。

以上内容来自Benzinga Earnings专栏,原文如下:

Heron Therapeutics (NASDAQ:HRTX) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.03) by 166.67 percent. This is a 128.57 percent increase over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $40.78 million which beat the analyst consensus estimate of $37.37 million by 9.14 percent. This is a 19.13 percent increase over sales of $34.23 million the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法